ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

メトヘキシタールナトリウム

Methohexital Sodium

HCID 23690443
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
309-36-4
標準SMILES
C=CCC1(C(C)C#CCC)C(=O)N=C([O-])N(C)C1=O.[Na+]
InChIKey
KDXZREBVGAGZHS-UHFFFAOYSA-M
分子式
C14H17N2NaO3
平均分子量
284.29 g/mol
単同位体質量
284.11368669

概要

Sodium methohexital is a white powder. (NTP, 1992)

名称と識別子

優先名称
Methohexital Sodium
IUPAC
sodium 5-hex-3-yn-2-yl-1-methyl-4,6-dioxo-5-prop-2-enylpyrimidin-2-olate
現地名
メトヘキシタールナトリウム
英語名
methohexital sodium
分子式
C14H18N2O3.Na
分子量
285.29

名称と別名

Methohexital sodiumSODIUM METHOHEXITALBrevital309-36-4Brietal sodiumMethohexitone sodiumBrevimytalBrevital SodiumEnallynymal sodiumSodium methohexitoneMethohexital sodium saltMethohexital sodium (USP)
名称をさらに表示
5-アリル-1-メチル-5-(1-メチル-2-ペンチニル)-2-ソジオオキシ-4,6(1H,5H)-ピリミジンジオンナトリウムメトヘキシタールブレビタールナトリウムナトリウムメトヘキシトンブリエタールナトリウムメトヘキシタールナトリウムメトヘキシトンナトリウムエナリニマールナトリウムブレビミタール5-(ヘキサ-3-イン-2-イル)-1-メチル-5-(プロパ-2-エン-1-イル)-2-(ソジオオキシ)-1,4,5,6-テトラヒドロピリミジン-4,6-ジオンLilly 22451Brevimytal.SODIUMMETHOHEXITALMETHOHEXITAL SODIUMQ: What is METHOHEXITAL SODIUM Q: What is the CAS Number of METHOHEXITAL SODIUM2,4,6(1H,3H,5H)-Pyrimidinetrione,1-methyl-5-(1-methyl-2-pentyn-1-yl)-5-(2-propen-1-yl)-, sodium salt (1:1)
Methohexital sodium [USP]CHEBI:6834Sodium 5-allyl-1-methyl-5-(1-methyl-2-pentynyl)barbiturateDTXSID602603660200PNZ7QBarbituric acid, 5-allyl-1-methyl-5-(1-methyl-2-pentynyl)-, sodium deriv.Barbituric acid, 5-allyl-1-methyl-5-(1-methyl-2-pentynyl)-, sodium saltBrietal sod

データベース識別子

CAS
309-36-4
PubChem CID
23690443
DTXSID
DTXSID6026036
ChEMBL
CHEMBL30219
ChEBI
CHEBI:6834
EC Number
206-217-9

物性

構造計算による物性

極性表面積
72.8 Ų
水素結合供与体数
0
水素結合受容体数
3
回転可能結合数
3
重原子数
20
形式電荷
0
複雑度
515

実験および物理化学的性質

Solubilitygreater than or equal to 100 mg/mL at 66 °F (NTP, 1992)
Human Drugs · 2 件

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Melting Point140 to 147 °F (NTP, 1992)
Physical DescriptionSodium methohexital is a white powder. (NTP, 1992)

物理化学的性質

CAS データベース
309 · 309-36-4
EPAの化学物質情報
Methohexital sodium (309-36-4)

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

危険有害性情報

DOT LabelPoison
Fire HazardsFlash point data are not available for this chemical, but it is probably combustible. (NTP, 1992)
Health Hazards · 1 件

SYMPTOMS: Allergic reactions to this chemical are manifested by redness and itching of the skin, shortness of breath, anxiety, abdominal pain, restlessness and peripheral vascular collapse. Other toxic reactions include nausea, vomiting, salivation, delirium, circulatory depression, thrombophlebitis, respiratory depression(including apnea), laryngospasm, bronchospasm and hiccups.

Reactive GroupAmides and Imides
Reactivity ProfileSolutions of this material are incompatible with silicone and acid. (NTP, 1992).
Air and Water ReactionsWater soluble.

安全と保護具

Fire FightingFires involving this compound should be controlled with a dry chemical, carbon dioxide or Halon extinguisher. (NTP, 1992)
First Aid · 1 件

EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.

Nonfire Spill Response · 1 件

SMALL SPILLS AND LEAKAGE: If you spill this chemical, you should dampen the solid spill material with water, then transfer the dampened material to a suitable container. Use absorbent paper dampened with water to pick up any remaining material. Seal your contaminated clothing and the absorbent paper in a vapor-tight plastic bag for eventual disposal. Wash all contaminated surfaces with a strong soap and water solution. Do not reenter the contaminated area until the Safety Officer (or other responsible person) has verified that the area has been properly cleaned.

Isolation and EvacuationExcerpt from ERG Guide 151 [Substances - Toxic (Non-Combustible)]:
Personal Protective Equipment (PPE) · 1 件

RECOMMENDED RESPIRATOR: Where the neat test chemical is weighed and diluted, wear a NIOSH-approved half face respirator equipped with a combination filter cartridge, i.e. organic vapor/acid gas/HEPA (specific for organic vapors, HCl, acid gas, SO2 and a high efficiency particulate filter). (NTP, 1992)

毒性情報

Treatment · 1 件

Establish an airway and ensure oxygenation and ventilation. Resuscitative measures should be initiated promptly. For hypotension, intravenous fluids should be administered and the patient's legs raised. If desirable increase in blood pressure is not obtained, vasopressor and/or inotropic drugs may be used as dictated by the clinical situation. For convulsions, diazepam intravenously and phenytoin may be required. If the seizures are refractory to diazepam and phenytoin, general anesthesia and paralysis with a neuromuscular blocking agent may be necessary. Protect the patient's airway and support ventilation and perfusion. Meticulously monitor and maintain, within acceptable limits, the patient's vital signs, blood gases, serum electrolytes, etc. Absorption of drugs from the gastrointestinal tract may be decreased by giving activated charcoal, which, in many cases, is more effective than emesis or lavage; consider charcoal instead of or in addition to gastric emptying. Repeated doses of charcoal over time may hasten elimination of some drugs that have been absorbed. Safeguard the patient's airway when employing gastric emptying or charcoal. (L1712)

Health EffectsThey cause slurred speech, disorientation and "drunken" behavior. They are physically and psychologically addictive.
Exposure RoutesParenteral (intramuscular, intravenous). The absolute bioavailability following rectal administration of methohexital is 17%.
Toxicity Summary · 1 件

Methohexital binds at a distinct binding site associated with a Cl<sup>-</sup> ionopore at the GABA<sub>A</sub> receptor, increasing the duration of time for which the Cl<sup>-</sup> ionopore is open. The post-synaptic inhibitory effect of GABA in the thalamus is, therefore, prolonged.

Signs and Symptoms · 1 件

The onset of toxicity following an overdose of intravenously administered methohexital will be within seconds of the infusion. If methohexital is administered rectally or is ingested, the onset of toxicity may be delayed. The manifestations of an ultrashort-acting barbiturate in overdose include central nervous system depression, respiratory depression, hypotension, loss of peripheral vascular resistance, and muscular hyperactivity ranging from twitching to convulsive-like movements. Other findings may include convulsions and allergic reactions.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 6 件

Drug Induced Liver Injury Rank (DILIrank 2.0)

Methohexital sodium

Ambiguous-DILI-concern

3

Adverse reactions

DOI:10.1016/j.drudis.2016.02.015

安全データ

ridadr
3249
hazard_class
6.1(b)
packing_group
III

化学と産業

薬理情報

Metabolism/Metabolites · 1 件

Metabolism occurs in the liver through demethylation and oxidation. Side-chain oxidation is the most important biotransformation involved in termination of biologic activity. Route of Elimination: Excretion occurs via the kidneys through glomerular filtration. Half Life: 5.6 &plusmn; 2.7 minutes

FDA Pharmacological Classification · 2 件

METHOHEXITAL SODIUM

Barbiturate [EPC]; Barbiturates [CS]

MeSH Pharmacological Classification · 1 件

Ultrashort-acting anesthetics that are used for induction. Loss of consciousness is rapid and induction is pleasant, but there is no muscle relaxation and reflexes frequently are not reduced adequately. Repeated administration results in accumulation and prolongs the recovery time. Since these agents have little if any analgesic activity, they are seldom used alone except in brief minor procedures. (From AMA Drug Evaluations Annual, 1994, p174)

用途と製造

UsesMethohexital is indicated for use as an intravenous anaesthetic. It has also been commonly used to induce deep sedation. It is only used in hospital or similar settings, under strict supervision.

応用分野

使用Anesthetic (intravenous).

一般的な説明White powder.

上流・下流製品情報

上流原料

硝酸マグネシウム·6水和物マロン酸ジエチルブロモエタン三臭化りんアセトアルデヒドアリルブロミドナトリウムエタノール1-メチル尿素

補足説明

定義ChEBI: The sodium salt of methohexital.

関連反応

0 件
反応記録を作成
関連する反応はまだありません

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート